Clinical Trial

Dual Stimulation for Spinal Cord Injury

Study acronym: DS-SCI
Completed
View on ClinicalTrials.gov →
Summary
The goal of this Spinal Cord Injury (SCI) Open-Label Clinical Trial is to test the safety and feasibility of the intervention. The study aims to answer whether implementing this intervention on inpatients at a specialized rehabilitation hospital is possible. All participants will receive the intervention and be asked to report side effects and tolerability. Additionally, injury markers for safety and signal recordings to detect changes will be assessed pre- and post-intervention.
Trial Details
NCT Number NCT07467850
Lead Sponsor Spaulding Rehabilitation Hospital
Collaborators: PathMaker Neurosystems Inc., Erchonia Corporation
Conditions Spinal Cord Injuries
Enrollment 8 participants
Start Date 2022-07-14
Primary Completion 2024-07-01 (estimated)
Study Completion 2024-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-12